Although the results of bioinformatics reported currently indicate that the abnormal expression of TRAF3IP2-AS1 in glioblastoma could be a biological marker of tumor progression [19], the specific biology function of TRAF3IP2-AS1 and the actual mechanism is still unknown. The gene discussed is TRAF3IP2; the disease is neoplasm.